Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$28.4B
1-Year Return
37.22%
This Quarter Return
-0.25%
1 Year Return
+37.22%
3 Year Return
+93.7%
5 Year Return
+199.54%
10 Year Return
+398.51%
AUM
$19.2B
AUM Growth
-$508M
(-2.6%)
Cap. Flow
-$251M
Cap. Flow
% of AUM
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
29.79%
Holding
1,281
New
321
Increased
325
Reduced
363
Closed
265
Top Buys
| 1 |
Thomson Reuters
TRI
|
$86.3M |
| 2 |
Waste Connections
WCN
|
$86.2M |
| 3 |
Fortis
FTS
|
$61.3M |
| 4 |
Linde
LIN
|
$59.4M |
| 5 |
Merck
MRK
|
$57.6M |
Top Sells
| 1 |
Canadian National Railway
CNI
|
$119M |
| 2 |
Visa
V
|
$84M |
| 3 |
Toronto Dominion Bank
TD
|
$71.9M |
| 4 |
Royal Bank of Canada
RY
|
$66M |
| 5 |
Enbridge
ENB
|
$64.9M |
Sector Composition
| 1 | Financials | 23.9% |
| 2 | Technology | 18.67% |
| 3 | Industrials | 11.52% |
| 4 | Communication Services | 9.28% |
| 5 | Energy | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
iShares Core S&P 500 ETF
IVV
$664B
| $3.26M | 0.02% |
7,572
| – | – |
|
427
Telefonica
TEF
$30.1B
| $3.26M | 0.02% |
741,635
+82,399
| +12% | +$362K |
|
428
Equifax
EFX
$30.8B
| $3.25M | 0.02% |
12,837
-3,586
| -22% | -$909K |
|
429
Quest Diagnostics
DGX
$20.5B
| $3.24M | 0.02% |
+22,302
| New | +$3.24M |
|
430
Bristol-Myers Squibb
BMY
$96B
| $3.24M | 0.02% |
+54,675
| New | +$3.24M |
|
431
Regenxbio
RGNX
$490M
| $3.24M | 0.02% |
+77,182
| New | +$3.24M |
|
432
Hartford Financial Services
HIG
$37B
| $3.21M | 0.02% |
+45,692
| New | +$3.21M |
|
433
Nu Skin
NUS
$569M
| $3.21M | 0.02% |
79,184
+13,135
| +20% | +$532K |
|
434
Cooper Companies
COO
$13.5B
| $3.2M | 0.02% |
31,004
-9,904
| -24% | -$1.02M |
|
435
Fiserv
FI
$73.4B
| $3.2M | 0.02% |
29,516
+21,331
| +261% | +$2.31M |
|
436
iShares MSCI EAFE ETF
EFA
$66.2B
| $3.18M | 0.02% |
40,791
| – | – |
|
437
Arcos Dorados Holdings
ARCO
$1.47B
| $3.18M | 0.02% |
621,252
-210,887
| -25% | -$1.08M |
|
438
Unum
UNM
$12.6B
| $3.06M | 0.02% |
+122,220
| New | +$3.06M |
|
439
Saia
SAIA
$8.34B
| $3.06M | 0.02% |
+12,866
| New | +$3.06M |
|
440
Travelers Companies
TRV
$62B
| $3.04M | 0.02% |
19,976
-26,760
| -57% | -$4.07M |
|
441
HCA Healthcare
HCA
$98.5B
| $3.03M | 0.02% |
+12,467
| New | +$3.03M |
|
442
Kornit Digital
KRNT
$687M
| $3.03M | 0.02% |
20,909
+11,951
| +133% | +$1.73M |
|
443
Rapid7
RPD
$1.32B
| $3.02M | 0.02% |
+26,710
| New | +$3.02M |
|
444
Bio-Rad Laboratories Class A
BIO
$8B
| $3M | 0.02% |
+4,017
| New | +$3M |
|
445
Commault Systems
CVLT
$7.96B
| $2.99M | 0.02% |
+39,634
| New | +$2.99M |
|
446
Dynatrace
DT
$15.1B
| $2.98M | 0.02% |
41,996
+14,409
| +52% | +$1.02M |
|
447
Chemed
CHE
$6.79B
| $2.94M | 0.02% |
6,326
-19,889
| -76% | -$9.25M |
|
448
Kosmos Energy
KOS
$784M
| $2.91M | 0.02% |
983,391
+808,457
| +462% | +$2.39M |
|
|
RDS.A
449
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.91M | 0.02% |
+65,209
| New | +$2.91M |
|
450
Bionano Genomics
BNGO
$18.7M
| $2.91M | 0.02% |
+880
| New | +$2.91M |
|